ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

Roswell Park Hired 31 Faculty In 2002 In Second Wave of Recruitment

November 22, 2002

NCI Programs: Unequal Outcomes For Minorities The Result of Unequal Treatment NCI Suggests Awareness Campaign

December 17, 1999

Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer”

May 1, 1992

Perifosine Increases PFS In Phase II Study

December 30, 2011

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975